APOA1 and ovarian cancer: These enhancements of in vitro antioxidant activity of HDL by BWA-rHDL are in good agreement with previous in vivo reports that showed a decrease in various oxidized lipids and enzymes involved in inflammation, such as COX-2, by apoA-I in colon cancer and ovarian cancer [52,53].